BeStock  
Stocks › Biotechnology › GPCR

Structure Therapeutics GPCR

US equityMarket cap rank #3061Biotechnology
$16.13 −$0.99 (-5.78%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.69 +3.47%
Open$16.73
Prev close$17.12
Day range$16.06 – $17.08
Volume786.2K
Market cap$1.15B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$103.67+542.7% vs. price
  • Buy 100%
Low $70.00Now $16.13Avg $103.67High $145.00

Recent rating changes

The last 20 actions on file set price targets from $70.00 to $145.00, averaging $100.61.

DateFirmRatingTarget
12 Nov 2026 H.C. Wainwright BUY $70.00
10 Nov 2026 CCORF BUY $107.00
10 Nov 2026 Piper Sandler BUY $93.00
10 Nov 2026 Stifel BUY $90.00
10 Nov 2026 BMO Capital BUY $145.00
9 Sep 2026 CCORF BUY $111.00
9 Sep 2026 H.C. Wainwright BUY $70.00
8 Sep 2026 LifeSci Capital BUY $104.00
8 Sep 2026 William Blair BUY –
8 Sep 2026 Jefferies BUY $125.00
8 Sep 2026 Clear Street BUY $99.00
17 Aug 2026 J.P. Morgan BUY $100.00
10 Aug 2026 Morgan Stanley BUY $126.00
10 Aug 2026 Citi BUY $97.00
7 Aug 2026 CCORF BUY $111.00
7 Aug 2026 William Blair BUY –
7 Aug 2026 Piper Sandler BUY $93.00
7 Aug 2026 Citizens JMP BUY $110.00
7 Aug 2026 Stifel BUY $90.00
7 Aug 2026 H.C. Wainwright BUY $70.00

Discussion

No comments yet — be the first to weigh in on GPCR.

Sign in to join the discussion.

Scroll to Top